Members of a bipartisan U.S. Senate 340B working group signaled that their long-awaited bill remains a work in progress amid [...] …
Exclusive
Several U.S. House lawmakers are in early talks to form a bipartisan 340B working group as a counterpart to the [...] …
Novartis has begun informing STD clinics that they will lose access to 340B pricing for all of the company’s products [...] …
Exclusive
Dr. Oz, Trump’s Pick to Lead CMS, Linked to Senior Role in Company that Partners With 340B Hospitals
Mehmet Oz, the celebrity heart surgeon and former U.S. Senate candidate that President Donald Trump nominated to lead the Centers [...] …
The West Virginia Board of Pharmacy is beginning to act on its growing backlog of alleged violations to the state’s [...] …
Exclusive
Former Senior Trump Official Talks Drug Pricing Reform, Says 340B Program Is ‘Out of Control’
A key official in the former Trump administration raised serious concerns with the 340B program during the keynote address at [...] …
A high-ranking federal regulator addressed the 340B patient definition and manufacturer audits during an unscripted Q&A session after a speech [...] …
Exclusive
Arkansas Plans to Challenge J&J’s Contested 340B Rebate Proposal for Violation of State Law
Arkansas plans to challenge Johnson & Johnson’s (J&J’s) 340B rebate proposal for violating the state’s law barring drugmaker contract pharmacy [...] …
Exclusive
Welch Likely to Introduce Senate Version of Matsui’s 340B PATIENTS Act As Soon As Next Week
A Vermont Democrat and longtime 340B advocate is expected to soon introduce a Senate version of the 340B Pharmaceutical Access [...] …
New Jersey-based drug manufacturing giant Merck and a large Wisconsin-based health system are the latest to join the 340B Working [...] …










